PureTech Health (LON:PRTC) Stock Breaks Above 50 Day Moving Average – What’s Next?

PureTech Health plc (LON:PRTC)’s stock price crossed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of GBX 116.86 and traded as high as GBX 119.20. PureTech Health shares last traded at GBX 119.20, with a volume of 7,430,262 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Peel Hunt reissued a “buy” rating and set a GBX 508 price target on shares of PureTech Health in a research report on Monday, July 13th. One research analyst has rated the stock with a Buy rating. Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of GBX 508.

PureTech Health Stock Performance

The company has a market capitalization of £290.78 million, a PE ratio of -2.34 and a beta of 0.77. The company has a debt-to-equity ratio of 4.78, a quick ratio of 2.51 and a current ratio of 4.60. The company has a 50 day moving average price of GBX 116.86 and a 200 day moving average price of GBX 123.77.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.